| 15.79 Data as of May 17 |  -0.76 / -4.59%Today’s Change | 10.74 Today|||52-Week Range 17.18 | -0.06% Year-to-Date |
| Alleged Patent Infringement by BSX - Analyst Blog May 17 / Zacks.com |
| Previous close | 16.55 |
| Today’s open | 16.59 |
| Day’s range | 15.31 - 16.59 |
| Volume | 145,195 |
| Average volume (3 months) | 67,392 |
| Market cap | $260.7M |
| Dividend yield | -- |
| Earnings growth (last year) | +5.26% |
| Earnings growth (this year) | +8.61% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +9.37% |
| P/E ratio | 25.5 |
| Price/Sales | 2.57 |
| Price/Book | 3.36 |
| Today’s change | Today’s % change | |
|---|---|---|
| RTIXRTI Biologics Inc | -0.05 | -1.14% |
| DSCIDerma Sciences Inc | -0.06 | -0.42% |
| STAASTAAR Surgical Co | +0.04 | +0.47% |
| ATECAlphatec Holdings In... | +0.04 | +2.05% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.17 |
| Annual revenue (last year) | $98.4M |
| Annual profit (last year) | $9.9M |
| Net profit margin | 10.07% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Howard C. Root |
Senior Vice President- Operations Charmaine Sutton |
Corporate headquarters Minneapolis, Minnesota |
.
